Hypersensitivity syndromes are severe drug induced side effects with s
kin rashes, fever and/or multiorgan-system abnormalities which are not
pharmacologically related. They are well known in relation to allopur
inol, anticonvulsants and sulfonamides, but only rarely described with
other drugs. These reactions are considered to be immune-mediated but
the precise mechanisms are not completely understood. Clinical featur
es, which resemble an EBV infection, and some immunological studies su
ggest that T-cell mediated immunity is involved in the pathogenesis of
this rare disease. In the literature, allopurinol and anticonvulsant
hypersensitivity syndromes are clinically well characterized entities,
while the definition of hypersensitivity syndrome elicited by other d
rugs is rather confusing. We present two patients, one with sulfometho
xazole- and one with allopurinol-induced hypersensitivity syndrome. In
both cases a lymphocyte transformation test (LTT) was performed and w
e analyzed the T-cell activation parameters CD25 and HLA-DR on CD4(+)
and CD8(+) T-cells to demonstrate in vivo activation of T-cells during
the active disease. Both patients show increased activation of T-cell
s with elevated levels of HLA-DR on CD8(+) cells. The T-cell activatio
n correlated with the clinical course. Our data support an immunologic
al pathogenesis for hypersensitivity syndromes and the concept that dr
ug specific T-cells are involved in hypersensitivity syndromes.